SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-21-000019
Filing Date
2021-05-17
Accepted
2021-05-17 16:08:45
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20210331.htm   iXBRL 10-Q 743547
2 EX-31.1 sum-ex311_2021331x10q.htm EX-31.1 11753
3 EX-31.2 sum-ex312_2021331x10q.htm EX-31.2 11449
4 EX-32.1 sum-ex321_2021331x10q.htm EX-32.1 7865
  Complete submission text file 0001599298-21-000019.txt   3930066

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20210331.xsd EX-101.SCH 33626
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20210331_cal.xml EX-101.CAL 43507
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20210331_def.xml EX-101.DEF 150298
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20210331_lab.xml EX-101.LAB 388420
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20210331_pre.xml EX-101.PRE 280375
10 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20210331_htm.xml XML 495790
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 21930550
SIC: 2834 Pharmaceutical Preparations